Search Within

Alexander Noor Shoushtari

  1. "GSK Faculty"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (31)
  3. Research Letter (6)
  4. Review (2)
Groups
  1. Department of Medicine (86)
  2. GSK Faculty (86)
  3. Hematologic Malignancies, Division of (86)
  4. Melanoma Disease Management Team (86)
  5. Melanoma and Immunotherapeutics Service (86)
  6. Solid Tumor Oncology Division (86)

More Groups

People
  1. Jedd Wolchok (49)
  2. Michael Postow (49)
  3. Paul Chapman (40)
  4. Margaret Callahan (37)
  5. Katherine Panageas (28)
  6. Parisa Momtaz (25)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (9)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (24)
  2. Clinical Cancer Research (7)
  3. Journal for ImmunoTherapy of Cancer (5)
  4. Nature Genetics (4)
  5. The Oncologist (4)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (11)
  3. Nature Publishing Group (9)
  4. Oxford University Press (6)
  5. Biomed Central Ltd (5)
  6. American Medical Association (4)

More Publishers

Results (86)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Most large structural variants in cancer genomes can be detected without long reads
    Journal Article

    Choo, Z. N.; Behr, J. M.; Deshpande, A.; Hadi, K.; Yao, X.; Tian, H.; Takai, K.; Zakusilo, G.; Rosiene, J.; Da Cruz Paula, A.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib
    Meeting Abstract

    Chapman, P. B.; Klang, M.; Postow, M. A.; Shoushtari, A. N.; Sullivan, R. J.; Wolchok, J. D.; Wong, P.; Callahan, M. K.; Zippin, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: Mutational signature analysis and immunotherapy response
    Journal Article

    Kasago, I. S.; Chatila, W. K.; Lezcano, C. M.; Febres-Aldana, C. A.; Schultz, N.; Vanderbilt, C.; Dogan, S.; Bartlett, E. K.; D'Angelo, S. P.; Tap, W. D.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save